REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot106710.21518/1561-5936-2019-04-21-23Original ArticleANALYSIS OF PATENT PORTFOLIOS IN THE ANTI-INFLUENZA DRUG SEGMENTVyukhinMikhail-RodninAlexey-ShulginVitaly-Patent Family Group041220194202318032022Copyright © 2019,2019According to statistics, 15% of the world’s population (of which the Russians account for 5-7%) is affected by seasonal influenza viruses during the cold season annually. The high prevalence of this disease, and the social significance of its prevention, determine the high priority of therapeutic areas aimed at combating influenza, which is characteristic of the global pharmaceutical industry in general. Experts of the Patent Family Group analytical centre studied the patent portfolios of the main players in the pharmaceutical market engaged in these areas to identify and evaluate, which areas in terms of the development and distribution of new medicinal products (drugs) dominate today in the Russian Federation.influenzaanti-influenza drugspatent activityгрипппротивогриппозные препаратыпатентная активность1.О мерах по профилактике гриппа в сезон 2018–2019 гг.. Режим доступа: http://www.61.rospotrebnadzor.ru/index.php?option=com_content&view=article&id=8272:-------2018-2019-&catid=38:2009-09-16-04-45-57&Itemid=57.2.О мерах по профилактике гриппа в сезон 2018–2019 гг.. Режим доступа: https://sev.gov.ru/info/messages/60949/.3.Итоги 2018 года. Розничный сегмент фармацевтического рынка России.. DSM Group. Режим доступа: https://www.dsm.ru/news/566/.